AI주식인사이트AI Stock Insight
B

세니젠

188260KOSDAQ그외 기타 제품 제조업

55.3 / 100

Reference Date: 2026-07-24

Financial Score10.0 / 40
News Sentiment21.3 / 25
Momentum12.0 / 20
Disclosure12.0 / 15
AI Analysis: the high debt ratio poses financial risk, PBR raises overvaluation concerns. Surged 25.2% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Senigen is a food safety specialist company established in 2005, leveraging advanced molecular diagnostic technologies like PCR and NGS to provide comprehensive food safety solutions. It has developed key products such as Genelix (high-sensitivity PCR) and GeNext (world's first NGS panel for foodborne pathogen detection), and is expanding into cosmetics and microbiome industries.

Number of Employees

72people

Average Salary

55.7M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 5.994.0Point
PBR
10.70Industry Average 0.790.0Point

13.5x industry avg (risky)

ROE
-108.63Industry Average -16.543.5Point

6.6x industry avg (excellent)

Debt Ratio
153.31Industry Average 11.460.0Point

13.4x industry avg (risky)

Trend 2023~20252.5 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼12.0% (2-year basis)

Operating Profit Growth Rate
2.5 / 3

Avg ▲17.4% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -84.6% (declining, 2yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position5.0Point

52w mid range (41%)

Current 1,998Won52-week high 2,73552-week low 1,484
1-month return6.0Point

1m +25.19% (strong rise)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

5 totalPositive 1Neutral 4Negative 0
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-10
  • Neutral주식등의대량보유상황보고서(일반)2026-07-10
  • Neutral주주총회소집공고2026-07-10
  • Positive증권발행결과(자율공시) (제3자배정 유상증자)2026-07-06
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-25